NEO100 Inquiry

PATIENT INQUIRY FOR NEO100 CLINICAL TRIAL

NEONC is conducting investigational clinical trials of NEO100 at select neuro-oncology centers in the United States.

A patient may qualify for this NEO100 study if the patient:

  •  Has a recurrent Grade 4 glioma (glioblastoma, glioblastoma multiforme)
  •  Has had prior surgery, radiation, and chemotherapy
  •  Is at least 18 years of age

Fields marked with an * are required

Comments are closed